Skip to main navigation Skip to search Skip to main content

Fucoxanthin: From chemical properties and sources to novel anticancer mechanistic insights and synergistic therapeutic opportunities

  • Wojciech Koch
  • , Wirginia Kukula-Koch
  • , Anna Wawruszak
  • , Estera Okoń
  • , Katarzyna Stępnik
  • , Katarzyna Gaweł-Bęben
  • , William N. Setzer
  • , Irene Dini
  • , Javad Sharifi-Rad
  • , Daniela Calina
  • Medical University of Lublin
  • Maria Curie–Sklodowska University in Lublin
  • University Of Information Technology And Management In Rzeszow
  • Aromatic Plant Research Center
  • University of Alabama in Huntsville
  • University of Naples Federico II
  • Universidad del Azuay
  • Craiova University of Medicine and Pharmacy

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Fucoxanthin (FX) is a carotenoid of marine origin primarily distributed in brown seaweeds and has garnered interest for its antioxidative, anti-inflammatory, and anticancer properties. Despite its potential, a comprehensive understanding of its anticancer effects and mechanisms of action remains elusive. The aim of this review is to present novel insights into the anticancer effects of FX, shedding light on previously unexplored molecular mechanisms and its synergistic potential with established chemotherapeutic agents. A comprehensive search was conducted employing databases like PubMed/MedLine, Scopus, and Web of Science to aggregate relevant pharmacological experimental studies. The results of the studies showed that FX exhibits anticancer activity against various cancer types, including breast, colorectal, and lung cancer, through multiple pathways: cell cycle arrest, apoptosis induction, and inhibition of angiogenesis. Additionally, FX potentiates the effects of existing chemotherapeutic agents, making it a potential candidate for combination therapies. The evidence suggests that FX possesses considerable anticancer properties, acting through diverse molecular mechanisms; the heterogeneity of study designs and the limited number of clinical trials make it hard to conclude. Further in-depth studies, particularly randomized controlled trials, are essential for validating FX's efficacy and for paving the way for its integration into standard cancer treatment regimens; additional research is needed to explore its pharmacokinetics, safety profile, and potential synergistic effects with existing chemotherapeutics.

Original languageEnglish
Article number100203
JournalCurrent Research in Biotechnology
Volume7
DOIs
StatePublished - Jan 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 14 - Life Below Water
    SDG 14 Life Below Water

Keywords

  • Angiogenesis
  • Apoptosis
  • Cell cycle arrest
  • Marine carotenoids

Fingerprint

Dive into the research topics of 'Fucoxanthin: From chemical properties and sources to novel anticancer mechanistic insights and synergistic therapeutic opportunities'. Together they form a unique fingerprint.

Cite this